I agree that this site is using cookies. You can find further informations here.
X
Hengel, Richard L
63  results:
Search for persons X
?
1

Sa1916 REAL WORLD OUTCOMES OF A NOVEL FECAL MICROBIOME REPL..:

Ritter, Timothy ; Rosenberg, Jonathan ; Hengel, Richard L....
Gastroenterology.  166 (2024)  5 - p. S-578-S-579 , 2024
Link: https://doi.org/10.1016/..
 
?
2

685. Early Experience with a Simple Administration of a Nov..:

Hengel, Richard L ; Krishnan, Sujatha ; Rosenberg, Jonathan A...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
3

1581. Weight and Metabolic Changes with Long-Acting Lenacap..:

Kumar, Princy N ; Goldstein, Deborah A ; Hengel, Richard L...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
4

674. Successful Management of ESBL Infections in Physician ..:

Nathan, Ramesh V ; Metzger, Brian S ; Bernett, Jorge R...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
5

Recurrent Clostridioides difficile infection worsens anxiet..:

Hengel, Richard L. ; Schroeder, Claudia P. ; Jo, Jinhee...
Journal of Patient-Reported Outcomes.  6 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
6

Appropriate cleaning reduces potential risk of spore transm..:

Schroeder, Claudia P. ; Hengel, Richard L. ; Nathan, Ramesh V....
Anaerobe.  77 (2022)  - p. 102617 , 2022
Link: https://doi.org/10.1016/..
 
?
7

598. A 3-Year Evaluation of Antibiotic Resistance Patterns ..:

Hengel, Richard L ; Metzger, Brian S ; Barry Baker, H...
Open Forum Infectious Diseases.  8 (2021)  Supplement_1 - p. S402-S403 , 2021
Link: https://doi.org/10.1093/..
 
?
8

Real-world Experience of Bezlotoxumab for Prevention of Clo..:

Garey, Kevin W ; Marcella, Stephen W ; Dillon, Ryan J...
Open Forum Infectious Diseases.  7 (2020)  4 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
9

1327. Vancomycin Dosing by AUC24/MIC in Comparison to Tradi..:

Luu, Quyen ; Adams, John S ; Metzger, Brian S...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S673-S674 , 2020
Link: https://doi.org/10.1093/..
 
?
10

787. Evaluation of Clostridioides difficile Environmental C..:

Garey, Kevin W ; Hengel, Richard L ; Ritter, Timothy E...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S438-S438 , 2020
Link: https://doi.org/10.1093/..
 
?
11

2382. Recurrent Clostridioides difficile Infection (CDI) Wo..:

Garey, Kevin W ; Schroeder, Claudia P ; Hardin, Thomas C...
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S822-S822 , 2019
Link: https://doi.org/10.1093/..
 
?
12

2081. Low 30-Day Hospital Readmission Rates in Medicare Pat..:

Luu, Quyen ; Baker, H Barry ; Nathan, Ramesh V...
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S702-S702 , 2019
Link: https://doi.org/10.1093/..
 
?
13

501. Evaluation of Bezlotoxumab in Prevention of Recurrent ..:

Hengel, Richard L ; Ritter, Timothy E ; Nathan, Ramesh V...
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S186-S186 , 2018
Link: https://doi.org/10.1093/..
 
?
14

Tu1887 - Real World Experience of Bezlotoxumab for Preventi..:

Ritter, Timothy E. ; Hengel, Richard L. ; Fitzsimmons, Curtis J....
Gastroenterology.  154 (2018)  6 - p. S-1048 , 2018
Link: https://doi.org/10.1016/..
 
?
15

1854. Effective Antimicrobial Stewardship for Outpatient Pa..:

Nathan, Ramesh V ; Hengel, Richard L ; Krinsky, Andrew H...
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S529-S530 , 2018
Link: https://doi.org/10.1093/..
 
1-15